New concepts in device therapy for advanced heart failure presented in early reports ...

A UK startup has built an AI-powered device capable of detecting signs of heart failure from a person’s feet. Cambridge-based Heartfelt Technologies says its technology can monitor discharged heart ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Abbott has secured the US Food and Drug Administration (FDA) approval for its next-generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring. The new pulmonary ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...

CHICAGO, Nov 14 (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that ...

CVRx’s stock has risen nearly 20% after the company revealed that its heart failure device is set to be investigated in an expanded patient population. In the BENEFIT-HF clinical trial (NCT07232030), ...

BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...

Heart failure affects 6.5 million people in the U.S., with an additional 550,000 newly diagnosed each year. Heart failure hospitalizations are a leading cause of admissions for those 65 and older, ...

Physicians at Emory University Hospital performed the first-ever surgical implantation in the United States of a brand-new type of heart pump designed to help save patients with heart failure, using a ...

Institutional investors in the United States have committed to buy $3.5 million-worth of Sunshine Heart Inc. (ASX: SHC) shares in a private placement — that is, if the company’s Australian ...